Otonomy Provides Business Update Related to COVID-19 Pandemic

Back to Jobs

SAN DIEGO , April 09, 2020 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today provided a business update related to the COVID-19 pandemic. “Our first priority during this international crisis

Apply Now